Strategy 11 min read May 15, 2026 Roy Redd

Physical Therapy Practice Valuation Multiples 2026: What Buyers Pay

Physical therapy practice valuation multiples in 2026: 4x–7x EBITDA depending on payer mix, location, and buyer type. Real comp data, SBA deal structures, and seller prep checklist.

Physical therapy practice acquisitions are running at an elevated pace in 2026, driven by two intersecting forces: the aging population is producing structural demand growth, and PE-backed outpatient therapy platforms are executing aggressive roll-up strategies across the country. If you own a PT practice — single location, multi-location, or specialty clinic — you are in an active seller's market with multiple buyer types competing for quality assets. But PT acquisitions have specific valuation drivers that differ from other healthcare businesses. Payer mix is the dominant variable: a practice with 40% commercial insurance revenue trades at a fundamentally different multiple than one with 70% Medicare. Staff credentialing, therapist retention, and state licensing compliance all affect whether a deal closes cleanly or dies in due diligence. This guide provides the current multiple ranges by practice size and type, explains who is buying and why, and gives you the specific preparation steps that maximize your sale price.

PT Practice Valuation Multiples by Practice Size: 2026 Data

Physical therapy practice valuations range from 4x–7x EBITDA in 2026, with significant variation driven by payer mix, location, therapist census, and buyer type. The following ranges reflect transaction activity in the lower middle market.

Practice TypeEBITDA RangeTypical MultiplePrimary Buyer
Single-location, general outpatient$250K–$600K4.0x–5.0xIndividual operator, search fund
Multi-location, regional$600K–$2M4.5x–6.0xPE platforms, regional strategics
Specialty or high-commercial mix$600K–$2M5.5x–7.0xPE-backed platforms, strategic acquirers
Large multi-site platform$2M+6.0x–7.5xPE, large therapy chains

Single-location general outpatient practices under $600K EBITDA typically trade at 4x–5x. The buyer pool at this size is limited to individual operators and search funds, often using SBA 7(a) financing. These practices frequently have one or two lead therapists whose patient relationships are central to revenue, creating key-person risk that buyers price into the multiple.

Multi-location practices and specialty clinics with $600K–$2M EBITDA attract a broader buyer pool and corresponding multiple expansion. PE-backed outpatient therapy platforms — companies executing regional or national roll-up strategies — are the most aggressive acquirers in this range. They pay 4.5x–6x and sometimes above when the practice has strong commercial insurance revenue, an established patient referral network, or specialty capability (sports medicine, vestibular, pediatric PT).

Practices with above-average commercial payer mix (50%+ commercial versus Medicare/Medicaid) command a meaningful premium. Commercial payers reimburse at higher rates with less regulatory exposure than government programs. A practice with 60% commercial insurance revenue generating $800K EBITDA can achieve 5.5x–7x from PE buyers who are specifically optimizing their platform portfolio for payer mix.

For current EBITDA multiples and deal structure data, see the physical therapy clinic valuation page.

Payer Mix: The Single Most Important Valuation Variable

No other factor affects physical therapy practice valuations as directly as payer mix. Sophisticated buyers — especially PE platforms — underwrite every acquisition to a normalized revenue per visit figure, and that figure varies dramatically by payer.

Commercial insurance payers (BlueCross, Aetna, United, Cigna, private plans) typically reimburse $120–$180 per PT visit in most markets. Medicare reimburses $85–$115 per visit and carries regulatory compliance requirements (PQRS reporting, therapy cap exceptions, audit exposure). Medicaid is the lowest-margin payer in most states and introduces payment delay risk. Workers' compensation and auto insurance are high-reimbursement but administratively intensive and case-duration dependent.

Buyers target practices with the following payer breakdown for maximum multiple: 50%+ commercial insurance, 25–35% Medicare, less than 15% Medicaid, and 5–15% workers' comp or self-pay. Practices with 60%+ Medicare are underwritten conservatively because Medicare reimbursement is subject to CMS rate adjustments and audit risk.

For sellers, the strategic implication is that growing commercial insurance revenue in the 12–24 months before going to market is the highest-leverage valuation improvement available. This means physician relationship marketing, direct-to-employer contracting, sports team partnerships, or corporate wellness agreements — any channel that generates commercially-insured patients versus Medicare referrals.

Practices that actively manage their referral mix, credentialing panel participation, and payer contract rates are rewarded with premium multiples. Practices that take whatever patients come through the door — without actively managing the payer distribution — are valued conservatively.

Who Is Buying PT Practices in 2026

Physical therapy practice acquisitions involve three buyer types with distinct valuation frameworks and deal structures.

PE-backed outpatient therapy platforms are the most active buyers for practices above $500K EBITDA. These platforms — regional and national outpatient PT companies backed by lower-middle-market PE funds — are executing multi-year roll-up strategies. Their acquisition logic is explicit: acquire practices at 4.5x–6x on a standalone basis, build a multi-site platform with centralized billing, compliance, and HR, and sell the combined platform at 7x–9x in 4–6 years. They offer all-cash closes, employment agreements for the selling PT owner, and sometimes equity rollover in the platform. For sellers, the rollover option can be valuable — keeping 15–20% equity in a platform that subsequently sells at a higher multiple generates total proceeds that often exceed the initial transaction price.

Strategic acquirers — larger PT groups, hospital systems, and health system outpatient divisions — buy for geographic coverage, referral network access, or specialty capability. Hospital systems in particular are strategic acquirers that pay above-market prices because they are acquiring patient access and physician alignment, not just EBITDA. A PT practice embedded in a primary care physician referral network near a hospital is strategically valuable beyond its standalone financials.

Individual operators and search funds are most active at the single-location level, typically using SBA 7(a) financing. A licensed physical therapist looking to own a practice (rather than building one from scratch), or a clinic manager transitioning to ownership, is a typical buyer in this tier. They underwrite conservatively on whether the practice can survive the transition of the selling owner and will pay premium multiples for practices that have documented clinical protocols, established referral relationships at the staff level, and systems that operate independently of the selling PT.

Therapist Retention: The Hidden Deal Risk

Physical therapy practices are people businesses. Revenue is generated by licensed therapists (PTs and PTAs) who maintain patient relationships, execute care plans, and drive patient satisfaction scores that affect referral volume. The departure of one or two key therapists post-acquisition can trigger patient attrition and referral network disruption that materially reduces the acquired practice's revenue.

Buyers diligence therapist retention risk explicitly. They will ask: what is your staff PT turnover rate over the past three years? Are any of your PTs approaching retirement or planning to leave? Do patients follow specific therapists, or do they have practice-level loyalty? Are your therapists employed or independent contractors?

For sellers, the strategic preparation work on therapist retention is twofold. First, ensure that your employed PTs are on employment agreements with non-solicitation clauses (where legally permissible in your state). This reduces the risk that a therapist departs post-close and takes patients to a competing practice. Second, ensure that key therapists are retained with equity or retention bonus arrangements that vest at or after close. Buyers are willing to pay for this certainty — a retention bonus funded at close from escrow is a standard deal mechanic for PE acquirers.

Clinics with high therapist tenure (average 3+ years), market-rate or above-market compensation, and documented career development paths are materially lower-risk acquisitions. Buyers will price that stability into the multiple.

SBA Financing for PT Practice Acquisitions

Physical therapy practices are SBA 7(a) eligible, and SBA financing is the primary acquisition vehicle for transactions in the $500K–$5M enterprise value range. Healthcare practices are viewed favorably by SBA lenders because of their established patient base, predictable insurance reimbursement, and essential service nature.

The standard SBA 7(a) deal structure for a PT acquisition: 10% equity injection from buyer ($100K on a $1M deal), SBA loan covering 80–85% of the purchase price, and 5–10% seller note on standby. Total cash required from the buyer on a $1M transaction is approximately $100K plus closing costs.

SBA lenders will focus on three PT-specific issues during underwriting. First, licensing continuity: is the selling PT the licensed holder of the clinic's state licensure? Can that license transfer, or does the acquiring buyer need to obtain their own state license? Second, payer credentialing: Medicare provider numbers and commercial insurance credentialing are practice-specific and require re-credentialing under new ownership. Lenders want to understand the credentialing timeline and whether there is a revenue gap during transition. Third, lease terms: many PT practices operate in medical office buildings with landlord approval requirements for lease assignment. SBA lenders require a confirmed lease assignment as a closing condition.

Sellers should get ahead of these issues before going to market. A legal opinion on license transferability, a credentialing timeline from your billing company, and a landlord consent conversation cost nothing and materially reduce the risk of SBA underwriting complications.

PT Practice Exit Preparation Checklist

The following preparation steps are consistent across successful PT practice sales. Completing this work 12–18 months before going to market maximizes multiple and minimizes diligence friction.

  • Prepare three years of P&L statements with payer mix breakdown by revenue — commercial, Medicare, Medicaid, workers' comp, self-pay
  • Calculate visits per week by therapist, revenue per visit by payer, and EBITDA margin — buyers will derive this from your records anyway
  • Review state licensing requirements — confirm whether your clinic license is transferable or requires new owner application
  • Audit Medicare and commercial credentialing panels — identify re-credentialing timelines for a new owner or entity
  • Confirm your key PTs are on employment agreements — add retention provisions for the top 2–3 producers if not already in place
  • Review your EMR and billing system — ensure your practice management software is current and billing records are clean
  • Review lease terms — confirm assignment rights and begin landlord relationship management if a consent conversation will be needed
  • Compile physician referral data by source — buyers want to see referral concentration and practice-level versus therapist-level loyalty
  • Document your new patient intake process and how referral relationships are managed so you can demonstrate transferability
  • Prepare a patient census snapshot: total active patients, average episode duration, and average revenue per patient

Frequently Asked Questions

What is a physical therapy practice worth in 2026?

Physical therapy practices in 2026 typically sell for 4x–7x EBITDA. Single-location general outpatient practices under $600K EBITDA typically achieve 4x–5x. Multi-location practices and specialty clinics with $600K–$2M EBITDA achieve 4.5x–6x with PE buyer competition. Practices with strong commercial payer mix (50%+ commercial insurance) command 5.5x–7x from PE-backed outpatient therapy platforms executing roll-up strategies. Payer mix is the most important valuation driver — commercial payers reimburse at significantly higher rates than Medicare.

How is a physical therapy practice valued?

PT practices are primarily valued on EBITDA (earnings before interest, taxes, depreciation, and amortization), adjusted to add back owner compensation above market rate and one-time expenses. Buyers also apply revenue per visit analysis by payer to verify the quality of EBITDA — a practice generating $150 per visit on 60% commercial insurance is more valuable than one generating $95 per visit on 70% Medicare, even with identical EBITDA. A secondary valuation metric is revenue multiple — most PT practices sell for 0.5x–1.2x annual revenue depending on margin profile.

Do PE firms buy physical therapy practices?

Yes. PE-backed outpatient therapy platforms are among the most active acquirers of PT practices in 2026. These platforms — typically regional or national PT chains backed by lower-middle-market PE funds — are acquiring practices above $500K EBITDA as part of deliberate roll-up strategies. They offer all-cash closes, above-market multiples, employment agreements for the selling owner, and equity rollover options that can produce total proceeds above the initial deal price if the platform subsequently sells at a higher multiple.

What happens to a PT practice after it is acquired by PE?

Post-acquisition by a PE-backed platform, most PT practices undergo centralization of back-office functions: billing, HR, payroll, credentialing, and compliance move to the platform. The clinical operation typically continues under the same branding (or rebrands to the platform's name), and the selling PT owner is usually retained in a clinical or supervisory role for 12–24 months under an employment agreement. Most PE-backed platforms prioritize clinical continuity because patient attrition and therapist turnover are the primary post-close risks.

How long does it take to sell a physical therapy practice?

Selling a PT practice typically takes 9–15 months from preparation to closing. This includes 2–3 months of financial normalization and preparation, 2–3 months of buyer outreach and LOI negotiation, and 3–5 months of due diligence and legal documentation. SBA-financed deals add 60–90 days to the closing timeline. Licensing and credentialing transfer are the most common sources of delay — sellers who address these issues proactively before going to market consistently close faster.

Physical therapy practice valuations in 2026 reward preparation and penalize ambiguity. A practice with strong commercial payer mix, documented referral relationships, retained therapists, and clean financial records achieves 5.5x–7x EBITDA. A practice with 70% Medicare, single-PT key-person dependency, and undocumented referral sources achieves 4x–5x. The preparation work to move from the low end to the high end of the range is achievable in 12–18 months and is entirely within the seller's control. For buyer profiles, deal structures, and current market data specific to physical therapy acquisitions, see the [physical therapy clinic valuation page](/valuation-multiples/physical-therapy-clinic). To connect with active buyers, see [PT practice listings and acquisition support](/sell/physical-therapy-clinic).

Connect With PT Practice Buyers

DealFlow OS connects physical therapy sellers with vetted buyers — PE-backed outpatient platforms, health system acquirers, and individual operators actively acquiring PT practices.

List Your PT Practice

Acquisition Guide

Ready to buy a Hypnotherapy Practice business? See EBITDA multiples, deal structures, SBA eligibility, and active targets in our full buyer guide.

Hypnotherapy Practice Acquisition Guide

Related Guides